Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women

Summary Objective  Hyperthyroidism is accompanied by low bone mass. Because the reference range of TSH levels is defined statistically, some individuals with low normal TSH levels may have mild hyperthyroidism and reduced bone mass. We therefore determined whether serum TSH levels correlate with bon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical endocrinology (Oxford) 2006-01, Vol.64 (1), p.86-90
Hauptverfasser: Kim, Duk Jae, Khang, Young Ho, Koh, Jung-Min, Shong, Young Kee, Kim, Ghi Su
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Objective  Hyperthyroidism is accompanied by low bone mass. Because the reference range of TSH levels is defined statistically, some individuals with low normal TSH levels may have mild hyperthyroidism and reduced bone mass. We therefore determined whether serum TSH levels correlate with bone mineral density (BMD). Design  A cross‐sectional hospital‐based survey. Participants  Nine hundred and fifty‐nine healthy postmenopausal women. Measurements  We measured BMD at the lumbar spine and femoral neck using dual energy X‐ray absorptiometry, and serum TSH concentrations using immunoluminometry. Results  BMD at the lumbar spine and femoral neck increased with TSH level (P for trend < 0·001 at both sites). Even after adjustment for age, years since menopause and body mass index, subjects with low normal TSH levels (0·5–1·1 mU/l) had significantly lower BMDs at the lumbar spine (0·863 ± 0·009 g/cm2vs 0·900 ± 0·009 g/cm2, P = 0·004) and femoral neck (0·660 ± 0·006 g/cm2vs 0·683 ± 0·006 g/cm2, P = 0·006) than those with high normal TSH levels (2·8–5·0 mU/l), as well as a 2·2‐fold increased risk of osteoporosis (95% confidence interval: 1·2–4·0). Conclusion  These results suggest that low normal TSH levels may not be physiological for postmenopausal women and, during treatment of hypothyroidism, may not be adequate for avoiding osteoporosis.
ISSN:0300-0664
1365-2265
DOI:10.1111/j.1365-2265.2005.02422.x